Environmental Engineering Reference
In-Depth Information
142. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la
Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node
metastases in prostate cancer. N Engl J Med 348(25):2491-2499
143. Bjornerud A, Johansson L (2004) The utility of superparamagnetic contrast agents in MRI:
theoretical consideration and applications in the cardiovascular system. NMR Biomed 17
(7):465-477
144. Jordan A, Scholz R, Wust P, Fahling H, Felix R (1999) Magnetic fluid hyperthermia (MFH):
cancer treatment with AC magnetic field induced excitation of biocompatible superpara-
magnetic nanoparticles. J Magn Magn Mater 201:413-419
145. Andra W, d
Ambly CG, Hergt R, Hilger I, Kaiser WA (1999) Temperature distribution as
function of time around a small spherical heat source of local magnetic hyperthermia. J Magn
Magn Mater 194(1-3):197-203
146. Hilger I, Hergt R, Kaiser WA (2000) Effects of magnetic thermoablation in muscle tissue
using iron oxide particles—an in vitro study. Invest Radiol 35(3):170-179
147. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM
(2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3(8):487-497
148. Pardoe H, Clark PR, St Pierre TG, Moroz P, Jones SK (2003) A magnetic resonance imaging
based method for measurement of tissue iron concentration in liver arterially embolized with
ferrimagnetic particles designed for magnetic hyperthermia treatment of tumors. Magn Reson
Imaging 21(5):483-488
149. Mornet S, Vasseur S, Grasset F, Duguet E (2004) Magnetic nanoparticle design for medical
diagnosis and therapy. J Mater Chem 14(14):2161-2175
150. L¨bbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K et al (1996) Clinical
experiences with magnetic drug targeting: a phase I study with 4
0
-epidoxorubicin in
14 patients with advanced solid tumors. Cancer Res 56(20):4686-4693
151. Bonadonna G, Gianni L, Santoro A, Bonfante V, Bidoli P, Casali P, Demicheli R, Valagussa
P (1993) Drugs 10 years later—epirubicin. Ann Oncol 4(5):359-369
152. L¨bbe AS, Bergemann C, Brock J, McClure DG (1999) Physiological aspects in magnetic
drug-targeting. J Magn Magn Mater 194(1-3):149-155
153. Frey NA, Peng S, Cheng K, Sun S (2009) Magnetic nanoparticles: synthesis, functiona-
lization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev 38
(9):2532-2542
'
